|
GNPTAB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.742000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.435900E-02 |
| Normal-vs-Stage2 |
2.352600E-01 |
| Normal-vs-Stage3 |
3.333400E-01 |
| Normal-vs-Stage4 |
8.371000E-01 |
| Stage1-vs-Stage2 |
8.740000E-01 |
| Stage1-vs-Stage3 |
4.605800E-01 |
| Stage1-vs-Stage4 |
4.922400E-02 |
| Stage2-vs-Stage3 |
7.156600E-01 |
| Stage2-vs-Stage4 |
2.140000E-01 |
| Stage3-vs-Stage4 |
3.160600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.070100E-02 |
| Normal-vs-AfricanAmerican |
2.010200E-01 |
| Normal-vs-Asian |
1.226160E-01 |
| Caucasian-vs-AfricanAmerican |
3.415600E-03 |
| Caucasian-vs-Asian |
5.343000E-01 |
| AfricanAmerican-vs-Asian |
6.569800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.575760E-01 |
| Normal-vs-Female |
9.777500E-02 |
| Male-vs-Female |
6.700000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.666600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.274760E-01 |
| Normal-vs-Age(61-80Yrs) |
6.643900E-02 |
| Normal-vs-Age(81-100Yrs) |
5.988000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.692000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.516800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.099800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.485600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.295600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.238400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.599600E-02 |
| Normal-vs-Grade 2 |
5.569600E-02 |
| Normal-vs-Grade 3 |
3.642400E-01 |
| Normal-vs-Grade 4 |
3.754800E-01 |
| Grade 1-vs-Grade 2 |
5.706400E-01 |
| Grade 1-vs-Grade 3 |
3.393600E-01 |
| Grade 1-vs-Grade 4 |
4.841000E-01 |
| Grade 2-vs-Grade 3 |
2.804800E-01 |
| Grade 2-vs-Grade 4 |
6.380600E-01 |
| Grade 3-vs-Grade 4 |
7.776600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.676200E-02 |
| Normal-vs-ccB subtype |
2.060200E-02 |
| ccA subtype-vs-ccB subtype |
7.041600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.083600E-02 |
| Normal-vs-N1 |
3.583400E-01 |
| N0-vs-N1 |
7.223400E-01 |
|
|
